ScripTakeda Pharmaceutical Co. Ltd. ’s HyQvia (immune globulin infusion 10% [human]/recombinant human hyaluronidase) was approved by the US Food and Drug Administration for chronic inflammatory demyelinati
Pink SheetJapan has set reimbursement prices for six new drugs under its national health insurance (NHI) scheme - including a gene therapy with the second-highest unit price ever for a therapeutic product in th
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Takes On XinThera’s Preclinical
Scrip1. Biogen/Eisai Get Another Shot At Alzheimer’s With Leqembi After the spectacular market failure of the Alzheimer’s disease (AD) drug Aduhelm (aducanumab), Eisai Co., Ltd. and Biogen, Inc. quickl